390 related articles for article (PubMed ID: 34147651)
21. Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.
Sassi MB; Ferjani S; Mkada I; Arbi M; Safer M; Elmoussi A; Abid S; Souiai O; Gharbi A; Tejouri A; Gaies E; Eljabri H; Ayed S; Hechaichi A; Daghfous R; Gouider R; Khelil JB; Kharrat M; Kacem I; Alya NB; Benkahla A; Trabelsi S; Boubaker IB
Infect Genet Evol; 2022 Aug; 102():105300. PubMed ID: 35552003
[TBL] [Abstract][Full Text] [Related]
22. A SARS-CoV-2 full genome sequence of the B.1.1 lineage sheds light on viral evolution in Sicily in late 2020.
Padilla-Blanco M; Gucciardi F; Rubio V; Lastra A; Lorenzo T; Ballester B; González-Pastor A; Veses V; Macaluso G; Sheth CC; Pascual-Ortiz M; Maiques E; Rubio-Guerri C; Purpari G; Guercio A
Front Public Health; 2023; 11():1098965. PubMed ID: 36778569
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 genomic surveillance in Costa Rica: Evidence of a divergent population and an increased detection of a spike T1117I mutation.
Molina-Mora JA; Cordero-Laurent E; Godínez A; Calderón-Osorno M; Brenes H; Soto-Garita C; Pérez-Corrales C; ; Drexler JF; Moreira-Soto A; Corrales-Aguilar E; Duarte-Martínez F
Infect Genet Evol; 2021 Aug; 92():104872. PubMed ID: 33905892
[TBL] [Abstract][Full Text] [Related]
24. Full-genome sequencing and mutation analysis of SARS-CoV-2 isolated from Makassar, South Sulawesi, Indonesia.
Massi MN; Abidin RS; Farouk AE; Halik H; Soraya GV; Hidayah N; Sjahril R; Handayani I; Hakim MS; Gazali FM; Setiawaty V; Wibawa T
PeerJ; 2022; 10():e13522. PubMed ID: 35707124
[TBL] [Abstract][Full Text] [Related]
25. The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection.
Goldswain H; Dong X; Penrice-Randal R; Alruwaili M; Shawli GT; Prince T; Williamson MK; Raghwani J; Randle N; Jones B; Donovan-Banfield I; Salguero FJ; Tree JA; Hall Y; Hartley C; Erdmann M; Bazire J; Jearanaiwitayakul T; Semple MG; Openshaw PJM; Baillie JK; ; Emmett SR; Digard P; Matthews DA; Turtle L; Darby AC; Davidson AD; Carroll MW; Hiscox JA
Genome Biol; 2023 Mar; 24(1):47. PubMed ID: 36915185
[TBL] [Abstract][Full Text] [Related]
26. Comparative mutational analysis of SARS-CoV-2 isolates from Pakistan and structural-functional implications using computational modelling and simulation approaches.
Shah A; Rehmat S; Aslam I; Suleman M; Batool F; Aziz A; Rashid F; Midrarullah ; Nawaz MA; Ali SS; Junaid M; Khan A; Wei DQ
Comput Biol Med; 2022 Feb; 141():105170. PubMed ID: 34968862
[TBL] [Abstract][Full Text] [Related]
27. SARS-CoV-2 genetic diversity and variants of concern in Saudi Arabia.
Obeid DA; Alsanea MS; Alnemari RT; Al-Qahtani AA; Althawadi SI; Mutabagani MS; Almaghrabi RS; Alhadheq FM; Alahideb BM; Alhamlan FS
J Infect Dev Ctries; 2021 Dec; 15(12):1782-1791. PubMed ID: 35044933
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 variants combining spike mutations and the absence of ORF8 may be more transmissible and require close monitoring.
Pereira F
Biochem Biophys Res Commun; 2021 Apr; 550():8-14. PubMed ID: 33676232
[TBL] [Abstract][Full Text] [Related]
29. SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
Ahmadi AS; Zadheidar S; Sadeghi K; Nejati A; Salimi V; Hajiabdolbaghi M; Mokhtari-Azad T; Yavarian J
J Med Virol; 2023 Jun; 95(6):e28877. PubMed ID: 37341553
[TBL] [Abstract][Full Text] [Related]
30. Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model.
Alam ASMRU; Islam OK; Hasan MS; Islam MR; Mahmud S; Al-Emran HM; Jahid IK; Crandall KA; Hossain MA
J Med Virol; 2022 Mar; 94(3):1035-1049. PubMed ID: 34676891
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East.
Gong YN; Tsao KC; Hsiao MJ; Huang CG; Huang PN; Huang PW; Lee KM; Liu YC; Yang SL; Kuo RL; Chen KF; Liu YC; Huang SY; Huang HI; Liu MT; Yang JR; Chiu CH; Yang CT; Chen GW; Shih SR
Emerg Microbes Infect; 2020 Dec; 9(1):1457-1466. PubMed ID: 32543353
[TBL] [Abstract][Full Text] [Related]
32. Genomic and proteomic mutation landscapes of SARS-CoV-2.
Badua CLDC; Baldo KAT; Medina PMB
J Med Virol; 2021 Mar; 93(3):1702-1721. PubMed ID: 32970329
[TBL] [Abstract][Full Text] [Related]
33. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiology of SARS-CoV-2 isolated from COVID-19 family clusters.
Gunadi ; Wibawa H; Hakim MS; Marcellus ; Trisnawati I; Khair RE; Triasih R; Irene ; Afiahayati ; Iskandar K; Siswanto ; Anggorowati N; Daniwijaya EW; Supriyati E; Nugrahaningsih DAA; Budiono E; Retnowulan H; Puspadewi Y; Puspitawati I; Sianipar O; Afandy D; Simanjaya S; Widitjiarso W; Puspitarani DA; Fahri F; Riawan U; Fauzi AR; Kalim AS; Ananda NR; Setyati A; Setyowireni D; Laksanawati IS; Arguni E; Nuryastuti T; Wibawa T;
BMC Med Genomics; 2021 Jun; 14(1):144. PubMed ID: 34074255
[TBL] [Abstract][Full Text] [Related]
35. Global and local mutations in Bangladeshi SARS-CoV-2 genomes.
Hasan MM; Das R; Rasheduzzaman M; Hussain MH; Muzahid NH; Salauddin A; Rumi MH; Mahbubur Rashid SM; Siddiki AZ; Mannan A
Virus Res; 2021 May; 297():198390. PubMed ID: 33737154
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
Pohl MO; Busnadiego I; Kufner V; Glas I; Karakus U; Schmutz S; Zaheri M; Abela I; Trkola A; Huber M; Stertz S; Hale BG
PLoS Biol; 2021 Mar; 19(3):e3001006. PubMed ID: 33760807
[TBL] [Abstract][Full Text] [Related]
37. SARS-Cov-2 ORF3a: Mutability and function.
Bianchi M; Borsetti A; Ciccozzi M; Pascarella S
Int J Biol Macromol; 2021 Feb; 170():820-826. PubMed ID: 33359807
[TBL] [Abstract][Full Text] [Related]
38. Assessment of basic reproduction number (R
Islam A; Sayeed MA; Rahman MK; Zamil S; Abedin J; Saha O; Hassan MM
Infect Genet Evol; 2021 Aug; 92():104884. PubMed ID: 33930563
[TBL] [Abstract][Full Text] [Related]
39. Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.
Ilmjärv S; Abdul F; Acosta-Gutiérrez S; Estarellas C; Galdadas I; Casimir M; Alessandrini M; Gervasio FL; Krause KH
Sci Rep; 2021 Jul; 11(1):13705. PubMed ID: 34210996
[TBL] [Abstract][Full Text] [Related]
40. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
